The Lymphoma Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation for Hodgkin and non-Hodgkin disease. Studies related to cellular therapy evaluating lymphoma-specific questions or those aiming to compare cellular therapy approaches (e.g. CAR-T vs. autologous transplant) are also entertained in collaboration with the Cellular Immunotherapy for Cancer Working Committee.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
2022
2022 Lymphoma Agenda
2021
2021 Lymphoma Status Report
2020
2020 Lymphoma Agenda
2020 Lymphoma Minutes and 2020-2021 Overview Plan
2019
2019 Lymphoma Agenda
2019 Lymphoma Minutes and 2019-2020 Overview Plan
2018
2018 Lymphoma Agenda
2018 Lymphoma Minutes and 2018-2019 Overview Plan
2017
2017 Lymphoma Minutes and 2017-2018 Overview Plan
2016
2016 Lymphoma Minutes and 2016-2017 Overview Plan
To view PDF documents you will need Adobe Reader.
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.
